- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
According to our latest study, the global Adipose Tissue Derived Stem Cell market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The stem cells from adipose tissue have a variety of uses, including research on stem cell differentiation, cell therapy, tissue engineering, and the creation of induced pluripotent stem cell lineages. These are rich in multipotent stem cells, adipocytes, osteocytes, chondrocytes, and other cell types can all be differentiated into adipocytes, osteocytes, and other cell types in vitro.
This report is a detailed and comprehensive analysis for global Adipose Tissue Derived Stem Cell market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Adipose Tissue Derived Stem Cell market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Adipose Tissue Derived Stem Cell market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Adipose Tissue Derived Stem Cell market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Adipose Tissue Derived Stem Cell market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Adipose Tissue Derived Stem Cell
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Adipose Tissue Derived Stem Cell market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, ThermoFisher Scientific Inc, Celprogen, Inc, iXCells Biotechnologies and Merck KGaA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Adipose Tissue Derived Stem Cell market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Source of Human Fat
Source of Animal Fat
Market segment by Application
Regenerative Medicine
Plastic Surgery
Other
Major players covered
Lonza
ThermoFisher Scientific Inc
Celprogen, Inc
iXCells Biotechnologies
Merck KGaA
Lifeline Cell Technology
AlloCure, Inc
Antria, Inc
Celgene Corporation
Cellleris SA
Corestem, Inc
Cytori Therapeutics, Inc
Intrexon, Inc
Mesoblast Ltd
Pluristem Therapeutics, Inc
Tissue Genesis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Adipose Tissue Derived Stem Cell product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Adipose Tissue Derived Stem Cell, with price, sales, revenue and global market share of Adipose Tissue Derived Stem Cell from 2018 to 2023.
Chapter 3, the Adipose Tissue Derived Stem Cell competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adipose Tissue Derived Stem Cell breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Adipose Tissue Derived Stem Cell market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Adipose Tissue Derived Stem Cell.
Chapter 14 and 15, to describe Adipose Tissue Derived Stem Cell sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Adipose Tissue Derived Stem Cell
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Adipose Tissue Derived Stem Cell Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Source of Human Fat
1.3.3 Source of Animal Fat
1.4 Market Analysis by Application
1.4.1 Overview: Global Adipose Tissue Derived Stem Cell Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Regenerative Medicine
1.4.3 Plastic Surgery
1.4.4 Other
1.5 Global Adipose Tissue Derived Stem Cell Market Size & Forecast
1.5.1 Global Adipose Tissue Derived Stem Cell Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Adipose Tissue Derived Stem Cell Sales Quantity (2018-2029)
1.5.3 Global Adipose Tissue Derived Stem Cell Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Adipose Tissue Derived Stem Cell Product and Services
2.1.4 Lonza Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lonza Recent Developments/Updates
2.2 ThermoFisher Scientific Inc
2.2.1 ThermoFisher Scientific Inc Details
2.2.2 ThermoFisher Scientific Inc Major Business
2.2.3 ThermoFisher Scientific Inc Adipose Tissue Derived Stem Cell Product and Services
2.2.4 ThermoFisher Scientific Inc Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 ThermoFisher Scientific Inc Recent Developments/Updates
2.3 Celprogen, Inc
2.3.1 Celprogen, Inc Details
2.3.2 Celprogen, Inc Major Business
2.3.3 Celprogen, Inc Adipose Tissue Derived Stem Cell Product and Services
2.3.4 Celprogen, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Celprogen, Inc Recent Developments/Updates
2.4 iXCells Biotechnologies
2.4.1 iXCells Biotechnologies Details
2.4.2 iXCells Biotechnologies Major Business
2.4.3 iXCells Biotechnologies Adipose Tissue Derived Stem Cell Product and Services
2.4.4 iXCells Biotechnologies Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 iXCells Biotechnologies Recent Developments/Updates
2.5 Merck KGaA
2.5.1 Merck KGaA Details
2.5.2 Merck KGaA Major Business
2.5.3 Merck KGaA Adipose Tissue Derived Stem Cell Product and Services
2.5.4 Merck KGaA Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Merck KGaA Recent Developments/Updates
2.6 Lifeline Cell Technology
2.6.1 Lifeline Cell Technology Details
2.6.2 Lifeline Cell Technology Major Business
2.6.3 Lifeline Cell Technology Adipose Tissue Derived Stem Cell Product and Services
2.6.4 Lifeline Cell Technology Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Lifeline Cell Technology Recent Developments/Updates
2.7 AlloCure, Inc
2.7.1 AlloCure, Inc Details
2.7.2 AlloCure, Inc Major Business
2.7.3 AlloCure, Inc Adipose Tissue Derived Stem Cell Product and Services
2.7.4 AlloCure, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AlloCure, Inc Recent Developments/Updates
2.8 Antria, Inc
2.8.1 Antria, Inc Details
2.8.2 Antria, Inc Major Business
2.8.3 Antria, Inc Adipose Tissue Derived Stem Cell Product and Services
2.8.4 Antria, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Antria, Inc Recent Developments/Updates
2.9 Celgene Corporation
2.9.1 Celgene Corporation Details
2.9.2 Celgene Corporation Major Business
2.9.3 Celgene Corporation Adipose Tissue Derived Stem Cell Product and Services
2.9.4 Celgene Corporation Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Celgene Corporation Recent Developments/Updates
2.10 Cellleris SA
2.10.1 Cellleris SA Details
2.10.2 Cellleris SA Major Business
2.10.3 Cellleris SA Adipose Tissue Derived Stem Cell Product and Services
2.10.4 Cellleris SA Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cellleris SA Recent Developments/Updates
2.11 Corestem, Inc
2.11.1 Corestem, Inc Details
2.11.2 Corestem, Inc Major Business
2.11.3 Corestem, Inc Adipose Tissue Derived Stem Cell Product and Services
2.11.4 Corestem, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Corestem, Inc Recent Developments/Updates
2.12 Cytori Therapeutics, Inc
2.12.1 Cytori Therapeutics, Inc Details
2.12.2 Cytori Therapeutics, Inc Major Business
2.12.3 Cytori Therapeutics, Inc Adipose Tissue Derived Stem Cell Product and Services
2.12.4 Cytori Therapeutics, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Cytori Therapeutics, Inc Recent Developments/Updates
2.13 Intrexon, Inc
2.13.1 Intrexon, Inc Details
2.13.2 Intrexon, Inc Major Business
2.13.3 Intrexon, Inc Adipose Tissue Derived Stem Cell Product and Services
2.13.4 Intrexon, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Intrexon, Inc Recent Developments/Updates
2.14 Mesoblast Ltd
2.14.1 Mesoblast Ltd Details
2.14.2 Mesoblast Ltd Major Business
2.14.3 Mesoblast Ltd Adipose Tissue Derived Stem Cell Product and Services
2.14.4 Mesoblast Ltd Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Mesoblast Ltd Recent Developments/Updates
2.15 Pluristem Therapeutics, Inc
2.15.1 Pluristem Therapeutics, Inc Details
2.15.2 Pluristem Therapeutics, Inc Major Business
2.15.3 Pluristem Therapeutics, Inc Adipose Tissue Derived Stem Cell Product and Services
2.15.4 Pluristem Therapeutics, Inc Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Pluristem Therapeutics, Inc Recent Developments/Updates
2.16 Tissue Genesis
2.16.1 Tissue Genesis Details
2.16.2 Tissue Genesis Major Business
2.16.3 Tissue Genesis Adipose Tissue Derived Stem Cell Product and Services
2.16.4 Tissue Genesis Adipose Tissue Derived Stem Cell Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Tissue Genesis Recent Developments/Updates
3 Competitive Environment: Adipose Tissue Derived Stem Cell by Manufacturer
3.1 Global Adipose Tissue Derived Stem Cell Sales Quantity by Manufacturer (2018-2023)
3.2 Global Adipose Tissue Derived Stem Cell Revenue by Manufacturer (2018-2023)
3.3 Global Adipose Tissue Derived Stem Cell Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Adipose Tissue Derived Stem Cell by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Adipose Tissue Derived Stem Cell Manufacturer Market Share in 2022
3.4.2 Top 6 Adipose Tissue Derived Stem Cell Manufacturer Market Share in 2022
3.5 Adipose Tissue Derived Stem Cell Market: Overall Company Footprint Analysis
3.5.1 Adipose Tissue Derived Stem Cell Market: Region Footprint
3.5.2 Adipose Tissue Derived Stem Cell Market: Company Product Type Footprint
3.5.3 Adipose Tissue Derived Stem Cell Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Adipose Tissue Derived Stem Cell Market Size by Region
4.1.1 Global Adipose Tissue Derived Stem Cell Sales Quantity by Region (2018-2029)
4.1.2 Global Adipose Tissue Derived Stem Cell Consumption Value by Region (2018-2029)
4.1.3 Global Adipose Tissue Derived Stem Cell Average Price by Region (2018-2029)
4.2 North America Adipose Tissue Derived Stem Cell Consumption Value (2018-2029)
4.3 Europe Adipose Tissue Derived Stem Cell Consumption Value (2018-2029)
4.4 Asia-Pacific Adipose Tissue Derived Stem Cell Consumption Value (2018-2029)
4.5 South America Adipose Tissue Derived Stem Cell Consumption Value (2018-2029)
4.6 Middle East and Africa Adipose Tissue Derived Stem Cell Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Adipose Tissue Derived Stem Cell Sales Quantity by Type (2018-2029)
5.2 Global Adipose Tissue Derived Stem Cell Consumption Value by Type (2018-2029)
5.3 Global Adipose Tissue Derived Stem Cell Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Adipose Tissue Derived Stem Cell Sales Quantity by Application (2018-2029)
6.2 Global Adipose Tissue Derived Stem Cell Consumption Value by Application (2018-2029)
6.3 Global Adipose Tissue Derived Stem Cell Average Price by Application (2018-2029)
7 North America
7.1 North America Adipose Tissue Derived Stem Cell Sales Quantity by Type (2018-2029)
7.2 North America Adipose Tissue Derived Stem Cell Sales Quantity by Application (2018-2029)
7.3 North America Adipose Tissue Derived Stem Cell Market Size by Country
7.3.1 North America Adipose Tissue Derived Stem Cell Sales Quantity by Country (2018-2029)
7.3.2 North America Adipose Tissue Derived Stem Cell Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Adipose Tissue Derived Stem Cell Sales Quantity by Type (2018-2029)
8.2 Europe Adipose Tissue Derived Stem Cell Sales Quantity by Application (2018-2029)
8.3 Europe Adipose Tissue Derived Stem Cell Market Size by Country
8.3.1 Europe Adipose Tissue Derived Stem Cell Sales Quantity by Country (2018-2029)
8.3.2 Europe Adipose Tissue Derived Stem Cell Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Adipose Tissue Derived Stem Cell Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Adipose Tissue Derived Stem Cell Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Adipose Tissue Derived Stem Cell Market Size by Region
9.3.1 Asia-Pacific Adipose Tissue Derived Stem Cell Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Adipose Tissue Derived Stem Cell Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Adipose Tissue Derived Stem Cell Sales Quantity by Type (2018-2029)
10.2 South America Adipose Tissue Derived Stem Cell Sales Quantity by Application (2018-2029)
10.3 South America Adipose Tissue Derived Stem Cell Market Size by Country
10.3.1 South America Adipose Tissue Derived Stem Cell Sales Quantity by Country (2018-2029)
10.3.2 South America Adipose Tissue Derived Stem Cell Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Adipose Tissue Derived Stem Cell Market Size by Country
11.3.1 Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Adipose Tissue Derived Stem Cell Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Adipose Tissue Derived Stem Cell Market Drivers
12.2 Adipose Tissue Derived Stem Cell Market Restraints
12.3 Adipose Tissue Derived Stem Cell Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Adipose Tissue Derived Stem Cell and Key Manufacturers
13.2 Manufacturing Costs Percentage of Adipose Tissue Derived Stem Cell
13.3 Adipose Tissue Derived Stem Cell Production Process
13.4 Adipose Tissue Derived Stem Cell Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Adipose Tissue Derived Stem Cell Typical Distributors
14.3 Adipose Tissue Derived Stem Cell Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Adipose Tissue Derived Stem Cell Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Adipose Tissue Derived Stem Cell Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Lonza Basic Information, Manufacturing Base and Competitors
Table 4. Lonza Major Business
Table 5. Lonza Adipose Tissue Derived Stem Cell Product and Services
Table 6. Lonza Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Lonza Recent Developments/Updates
Table 8. ThermoFisher Scientific Inc Basic Information, Manufacturing Base and Competitors
Table 9. ThermoFisher Scientific Inc Major Business
Table 10. ThermoFisher Scientific Inc Adipose Tissue Derived Stem Cell Product and Services
Table 11. ThermoFisher Scientific Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. ThermoFisher Scientific Inc Recent Developments/Updates
Table 13. Celprogen, Inc Basic Information, Manufacturing Base and Competitors
Table 14. Celprogen, Inc Major Business
Table 15. Celprogen, Inc Adipose Tissue Derived Stem Cell Product and Services
Table 16. Celprogen, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Celprogen, Inc Recent Developments/Updates
Table 18. iXCells Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 19. iXCells Biotechnologies Major Business
Table 20. iXCells Biotechnologies Adipose Tissue Derived Stem Cell Product and Services
Table 21. iXCells Biotechnologies Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. iXCells Biotechnologies Recent Developments/Updates
Table 23. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 24. Merck KGaA Major Business
Table 25. Merck KGaA Adipose Tissue Derived Stem Cell Product and Services
Table 26. Merck KGaA Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Merck KGaA Recent Developments/Updates
Table 28. Lifeline Cell Technology Basic Information, Manufacturing Base and Competitors
Table 29. Lifeline Cell Technology Major Business
Table 30. Lifeline Cell Technology Adipose Tissue Derived Stem Cell Product and Services
Table 31. Lifeline Cell Technology Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Lifeline Cell Technology Recent Developments/Updates
Table 33. AlloCure, Inc Basic Information, Manufacturing Base and Competitors
Table 34. AlloCure, Inc Major Business
Table 35. AlloCure, Inc Adipose Tissue Derived Stem Cell Product and Services
Table 36. AlloCure, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. AlloCure, Inc Recent Developments/Updates
Table 38. Antria, Inc Basic Information, Manufacturing Base and Competitors
Table 39. Antria, Inc Major Business
Table 40. Antria, Inc Adipose Tissue Derived Stem Cell Product and Services
Table 41. Antria, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Antria, Inc Recent Developments/Updates
Table 43. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 44. Celgene Corporation Major Business
Table 45. Celgene Corporation Adipose Tissue Derived Stem Cell Product and Services
Table 46. Celgene Corporation Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Celgene Corporation Recent Developments/Updates
Table 48. Cellleris SA Basic Information, Manufacturing Base and Competitors
Table 49. Cellleris SA Major Business
Table 50. Cellleris SA Adipose Tissue Derived Stem Cell Product and Services
Table 51. Cellleris SA Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Cellleris SA Recent Developments/Updates
Table 53. Corestem, Inc Basic Information, Manufacturing Base and Competitors
Table 54. Corestem, Inc Major Business
Table 55. Corestem, Inc Adipose Tissue Derived Stem Cell Product and Services
Table 56. Corestem, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Corestem, Inc Recent Developments/Updates
Table 58. Cytori Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 59. Cytori Therapeutics, Inc Major Business
Table 60. Cytori Therapeutics, Inc Adipose Tissue Derived Stem Cell Product and Services
Table 61. Cytori Therapeutics, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Cytori Therapeutics, Inc Recent Developments/Updates
Table 63. Intrexon, Inc Basic Information, Manufacturing Base and Competitors
Table 64. Intrexon, Inc Major Business
Table 65. Intrexon, Inc Adipose Tissue Derived Stem Cell Product and Services
Table 66. Intrexon, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Intrexon, Inc Recent Developments/Updates
Table 68. Mesoblast Ltd Basic Information, Manufacturing Base and Competitors
Table 69. Mesoblast Ltd Major Business
Table 70. Mesoblast Ltd Adipose Tissue Derived Stem Cell Product and Services
Table 71. Mesoblast Ltd Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Mesoblast Ltd Recent Developments/Updates
Table 73. Pluristem Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 74. Pluristem Therapeutics, Inc Major Business
Table 75. Pluristem Therapeutics, Inc Adipose Tissue Derived Stem Cell Product and Services
Table 76. Pluristem Therapeutics, Inc Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pluristem Therapeutics, Inc Recent Developments/Updates
Table 78. Tissue Genesis Basic Information, Manufacturing Base and Competitors
Table 79. Tissue Genesis Major Business
Table 80. Tissue Genesis Adipose Tissue Derived Stem Cell Product and Services
Table 81. Tissue Genesis Adipose Tissue Derived Stem Cell Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Tissue Genesis Recent Developments/Updates
Table 83. Global Adipose Tissue Derived Stem Cell Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 84. Global Adipose Tissue Derived Stem Cell Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Adipose Tissue Derived Stem Cell Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 86. Market Position of Manufacturers in Adipose Tissue Derived Stem Cell, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Adipose Tissue Derived Stem Cell Production Site of Key Manufacturer
Table 88. Adipose Tissue Derived Stem Cell Market: Company Product Type Footprint
Table 89. Adipose Tissue Derived Stem Cell Market: Company Product Application Footprint
Table 90. Adipose Tissue Derived Stem Cell New Market Entrants and Barriers to Market Entry
Table 91. Adipose Tissue Derived Stem Cell Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Adipose Tissue Derived Stem Cell Sales Quantity by Region (2018-2023) & (K Units)
Table 93. Global Adipose Tissue Derived Stem Cell Sales Quantity by Region (2024-2029) & (K Units)
Table 94. Global Adipose Tissue Derived Stem Cell Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Adipose Tissue Derived Stem Cell Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Adipose Tissue Derived Stem Cell Average Price by Region (2018-2023) & (US$/Unit)
Table 97. Global Adipose Tissue Derived Stem Cell Average Price by Region (2024-2029) & (US$/Unit)
Table 98. Global Adipose Tissue Derived Stem Cell Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Global Adipose Tissue Derived Stem Cell Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Global Adipose Tissue Derived Stem Cell Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Adipose Tissue Derived Stem Cell Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Adipose Tissue Derived Stem Cell Average Price by Type (2018-2023) & (US$/Unit)
Table 103. Global Adipose Tissue Derived Stem Cell Average Price by Type (2024-2029) & (US$/Unit)
Table 104. Global Adipose Tissue Derived Stem Cell Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Global Adipose Tissue Derived Stem Cell Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Global Adipose Tissue Derived Stem Cell Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Adipose Tissue Derived Stem Cell Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Adipose Tissue Derived Stem Cell Average Price by Application (2018-2023) & (US$/Unit)
Table 109. Global Adipose Tissue Derived Stem Cell Average Price by Application (2024-2029) & (US$/Unit)
Table 110. North America Adipose Tissue Derived Stem Cell Sales Quantity by Type (2018-2023) & (K Units)
Table 111. North America Adipose Tissue Derived Stem Cell Sales Quantity by Type (2024-2029) & (K Units)
Table 112. North America Adipose Tissue Derived Stem Cell Sales Quantity by Application (2018-2023) & (K Units)
Table 113. North America Adipose Tissue Derived Stem Cell Sales Quantity by Application (2024-2029) & (K Units)
Table 114. North America Adipose Tissue Derived Stem Cell Sales Quantity by Country (2018-2023) & (K Units)
Table 115. North America Adipose Tissue Derived Stem Cell Sales Quantity by Country (2024-2029) & (K Units)
Table 116. North America Adipose Tissue Derived Stem Cell Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Adipose Tissue Derived Stem Cell Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Adipose Tissue Derived Stem Cell Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Europe Adipose Tissue Derived Stem Cell Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Europe Adipose Tissue Derived Stem Cell Sales Quantity by Application (2018-2023) & (K Units)
Table 121. Europe Adipose Tissue Derived Stem Cell Sales Quantity by Application (2024-2029) & (K Units)
Table 122. Europe Adipose Tissue Derived Stem Cell Sales Quantity by Country (2018-2023) & (K Units)
Table 123. Europe Adipose Tissue Derived Stem Cell Sales Quantity by Country (2024-2029) & (K Units)
Table 124. Europe Adipose Tissue Derived Stem Cell Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Adipose Tissue Derived Stem Cell Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Adipose Tissue Derived Stem Cell Sales Quantity by Type (2018-2023) & (K Units)
Table 127. Asia-Pacific Adipose Tissue Derived Stem Cell Sales Quantity by Type (2024-2029) & (K Units)
Table 128. Asia-Pacific Adipose Tissue Derived Stem Cell Sales Quantity by Application (2018-2023) & (K Units)
Table 129. Asia-Pacific Adipose Tissue Derived Stem Cell Sales Quantity by Application (2024-2029) & (K Units)
Table 130. Asia-Pacific Adipose Tissue Derived Stem Cell Sales Quantity by Region (2018-2023) & (K Units)
Table 131. Asia-Pacific Adipose Tissue Derived Stem Cell Sales Quantity by Region (2024-2029) & (K Units)
Table 132. Asia-Pacific Adipose Tissue Derived Stem Cell Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Adipose Tissue Derived Stem Cell Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Adipose Tissue Derived Stem Cell Sales Quantity by Type (2018-2023) & (K Units)
Table 135. South America Adipose Tissue Derived Stem Cell Sales Quantity by Type (2024-2029) & (K Units)
Table 136. South America Adipose Tissue Derived Stem Cell Sales Quantity by Application (2018-2023) & (K Units)
Table 137. South America Adipose Tissue Derived Stem Cell Sales Quantity by Application (2024-2029) & (K Units)
Table 138. South America Adipose Tissue Derived Stem Cell Sales Quantity by Country (2018-2023) & (K Units)
Table 139. South America Adipose Tissue Derived Stem Cell Sales Quantity by Country (2024-2029) & (K Units)
Table 140. South America Adipose Tissue Derived Stem Cell Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Adipose Tissue Derived Stem Cell Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity by Type (2018-2023) & (K Units)
Table 143. Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity by Type (2024-2029) & (K Units)
Table 144. Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity by Application (2018-2023) & (K Units)
Table 145. Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity by Application (2024-2029) & (K Units)
Table 146. Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity by Region (2018-2023) & (K Units)
Table 147. Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity by Region (2024-2029) & (K Units)
Table 148. Middle East & Africa Adipose Tissue Derived Stem Cell Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Adipose Tissue Derived Stem Cell Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Adipose Tissue Derived Stem Cell Raw Material
Table 151. Key Manufacturers of Adipose Tissue Derived Stem Cell Raw Materials
Table 152. Adipose Tissue Derived Stem Cell Typical Distributors
Table 153. Adipose Tissue Derived Stem Cell Typical Customers
List of Figures
Figure 1. Adipose Tissue Derived Stem Cell Picture
Figure 2. Global Adipose Tissue Derived Stem Cell Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Adipose Tissue Derived Stem Cell Consumption Value Market Share by Type in 2022
Figure 4. Source of Human Fat Examples
Figure 5. Source of Animal Fat Examples
Figure 6. Global Adipose Tissue Derived Stem Cell Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Adipose Tissue Derived Stem Cell Consumption Value Market Share by Application in 2022
Figure 8. Regenerative Medicine Examples
Figure 9. Plastic Surgery Examples
Figure 10. Other Examples
Figure 11. Global Adipose Tissue Derived Stem Cell Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Adipose Tissue Derived Stem Cell Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Adipose Tissue Derived Stem Cell Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Adipose Tissue Derived Stem Cell Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Adipose Tissue Derived Stem Cell Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Adipose Tissue Derived Stem Cell by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Adipose Tissue Derived Stem Cell Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Adipose Tissue Derived Stem Cell Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Adipose Tissue Derived Stem Cell Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Adipose Tissue Derived Stem Cell Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Adipose Tissue Derived Stem Cell Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Adipose Tissue Derived Stem Cell Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Adipose Tissue Derived Stem Cell Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Adipose Tissue Derived Stem Cell Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Adipose Tissue Derived Stem Cell Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Adipose Tissue Derived Stem Cell Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Adipose Tissue Derived Stem Cell Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Adipose Tissue Derived Stem Cell Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Adipose Tissue Derived Stem Cell Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Adipose Tissue Derived Stem Cell Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Adipose Tissue Derived Stem Cell Consumption Value Market Share by Region (2018-2029)
Figure 53. China Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Adipose Tissue Derived Stem Cell Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Adipose Tissue Derived Stem Cell Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Adipose Tissue Derived Stem Cell Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Adipose Tissue Derived Stem Cell Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Adipose Tissue Derived Stem Cell Market Drivers
Figure 74. Adipose Tissue Derived Stem Cell Market Restraints
Figure 75. Adipose Tissue Derived Stem Cell Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Adipose Tissue Derived Stem Cell in 2022
Figure 78. Manufacturing Process Analysis of Adipose Tissue Derived Stem Cell
Figure 79. Adipose Tissue Derived Stem Cell Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
